BackCassava Sciences Overview

Cassava Sciences Current Cash

Cassava Sciences's current cash is $83M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$82.68M
26.43% YoYΔ $-29.70M vs prior year quarter

Peer trimmed avg / median

Loading

Cassava Sciences Current Cash History

Loading

Cassava Sciences vs. peers: Current Cash Comparison

Loading

Cassava Sciences Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Cassava Sciences (SAVA) FAQ

The latest current cash for SAVA is $83M as of June 2026. That compares with $110M in the prior-year period — down 26.4% year over year. Investors often review this figure alongside Cassava Sciences's historical trend and sector peers before judging valuation or financial health.

Over the past year, SAVA's current cash moved from $110M to $83M — a 26.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Cassava Sciences's operating scale or balance-sheet position.

A current cash figure of $83M for SAVA is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting SAVA's current cash ($83M), review year-over-year change from $110M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Cassava Sciences's current cash against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.